EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?

Detalles Bibliográficos
Autores principales: Tfelt-Hansen, P, Kauffmann, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182244/
http://dx.doi.org/10.1186/1129-2377-15-S1-G37
_version_ 1782337502737072128
author Tfelt-Hansen, P
Kauffmann, J
author_facet Tfelt-Hansen, P
Kauffmann, J
author_sort Tfelt-Hansen, P
collection PubMed
description
format Online
Article
Text
id pubmed-4182244
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-41822442014-10-02 EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ? Tfelt-Hansen, P Kauffmann, J J Headache Pain Meeting Abstract Springer 2014 2014-09-18 /pmc/articles/PMC4182244/ http://dx.doi.org/10.1186/1129-2377-15-S1-G37 Text en Copyright © 2014 Tfelt-Hansen and Kauffmann; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Tfelt-Hansen, P
Kauffmann, J
EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
title EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
title_full EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
title_fullStr EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
title_full_unstemmed EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
title_short EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
title_sort ehmti-0120. are the ihs’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182244/
http://dx.doi.org/10.1186/1129-2377-15-S1-G37
work_keys_str_mv AT tfelthansenp ehmti0120aretheihsrecommendationsforevaluationandregistrationofadverseeventsindrugtrialsinmigrainebeingfollowed
AT kauffmannj ehmti0120aretheihsrecommendationsforevaluationandregistrationofadverseeventsindrugtrialsinmigrainebeingfollowed

Ejemplares similares